GlassScriptPhysician profile
Whitney Lipscomb
NPI 1215714522
$3,200.27
in general payments reported to CMS, 2019-2025
13 companies · $1,984 in 2025
The $1,984 reported for 2025 was more than what 92% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,216 · 2025: $1,984.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,096 · Education: $104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,096.29 |
| Education | $103.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $963.65 | 2024-2025 | Invega Sustenna, Invega Trinza, Spravato |
| Teva Pharmaceuticals USA, INC. | $446.08 | 2024-2025 | Austedo Xr, Austedo Xr, Uzedy |
| Otsuka America Pharmaceutical, INC. | $361.20 | 2024-2025 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Alkermes, INC. | $289.19 | 2024-2025 | Aristada, Lybalvi, Aristada Initio |
| E.R. Squibb & Sons, L.L.C. | $211.18 | 2024-2025 | Cobenfy |
| Neurocrine Biosciences, INC. | $207.61 | 2024-2025 | Ingrezza |
| Abbvie INC. | $207.36 | 2024-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $168.35 | 2025 | Caplyta |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $144.08 | 2024-2025 | |
| Vanda Pharmaceuticals INC. | $78.42 | 2024 | Fanapt |
| Janssen Scientific Affairs, LLC | $72.71 | 2024 | Invega Sustenna |
| Viiv Healthcare Company | $30.85 | 2025 | Apretude |
| Luye Pharma (USA) LTD. | $19.59 | 2025 | Erzofri Extended-Release |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitney Lipscomb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.